Graeme J Hankey1. Show Affiliations » 1. Stroke Unit, Department of Neurology, Royal Perth Hospital, Perth, WA 6000, Australia. gjhankey@cyllene.uwa.edu.au
Abstract
Entities: Disease
Mesh: See more » Angiotensin II Type 1 Receptor Blockers/administration & dosageAngiotensin II Type 1 Receptor Blockers/adverse effectsAngiotensin II Type 1 Receptor Blockers/therapeutic useAntihypertensive Agents/administration & dosageAntihypertensive Agents/adverse effectsAntihypertensive Agents/therapeutic useBenzimidazoles/administration & dosageBenzimidazoles/adverse effectsBenzimidazoles/therapeutic useBlood Pressure/drug effectsClinical Trials as TopicEvidence-Based MedicineHumansHypertension/drug therapyHypertension/physiopathologyMulticenter Studies as TopicOdds RatioRandomized Controlled Trials as TopicStroke/drug therapyStroke/etiologyStroke/physiopathologyTetrazoles/administration & dosageTetrazoles/adverse effectsTetrazoles/therapeutic useTime FactorsTreatment Failure
Substances: See more » Angiotensin II Type 1 Receptor BlockersAntihypertensive AgentsBenzimidazolesTetrazolescandesartan
Year: 2011 PMID: 21316753 DOI: 10.1016/S0140-6736(11)60163-3
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321